HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Clinical trials for HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill shows promise against tough breast cancer
Disease control CompletedThis study tested a new daily pill, OP-1250, in 153 adults with advanced or metastatic hormone receptor-positive, HER2-negative breast cancer. The goal was to find the right dose, check safety, and see if the drug can shrink tumors. Participants had already tried at least one hor…
Matched conditions: HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Olema Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
New program eases joint pain for breast cancer survivors on hormone pills
Symptom relief CompletedThis study tested a special pain program for breast cancer survivors who have joint and muscle pain from taking aromatase inhibitors. The program aimed to reduce pain, improve mood and daily function, and help patients keep taking their medication. 105 women with early-stage horm…
Matched conditions: HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 26, 2026 05:04 UTC